Gender differences of venous thromboembolism risk after total hip and total knee arthroplasty: a meta-analysis

2015 ◽  
Vol 41 (4) ◽  
pp. 556-562 ◽  
Author(s):  
Yue Lu ◽  
Zhen-Yu Zhou ◽  
Ya-Ke Liu ◽  
Hong-Lin Chen ◽  
Hui-Lin Yang ◽  
...  
2015 ◽  
Vol 135 (6) ◽  
pp. 759-772 ◽  
Author(s):  
Jie Zhang ◽  
Zhihao Chen ◽  
Jilin Zheng ◽  
Steffen J Breusch ◽  
Jing Tian

Author(s):  
Hui Ping Tay ◽  
Xinyi Wang ◽  
Sujita W Narayan ◽  
Jonathan Penm ◽  
Asad E Patanwala

Abstract Disclaimer In an effort to expedite the publication of articles related to the COVID-19 pandemic, AJHP is posting these manuscripts online as soon as possible after acceptance. Accepted manuscripts have been peer-reviewed and copyedited, but are posted online before technical formatting and author proofing. These manuscripts are not the final version of record and will be replaced with the final article (formatted per AJHP style and proofed by the authors) at a later time. Purpose To identify the proportion of patients with continued opioid use after total hip or knee arthroplasty. Methods This systematic review and meta-analysis searched Embase, MEDLINE, the Cochrane Central Register of Controlled Trials, and International Pharmaceutical Abstracts for articles published from January 1, 2009, to May 26, 2021. The search terms (opioid, postoperative, hospital discharge, total hip or knee arthroplasty, and treatment duration) were based on 5 key concepts. We included studies of adults who underwent total hip or knee arthroplasty, with at least 3 months postoperative follow-up. Results There were 30 studies included. Of these, 17 reported on outcomes of total hip arthroplasty and 19 reported on outcomes of total knee arthroplasty, with some reporting on outcomes of both procedures. In patients having total hip arthroplasty, rates of postoperative opioid use at various time points were as follows: at 3 months, 20% (95% CI, 13%-26%); at 6 months, 17% (95% CI, 12%-21%); at 9 months, 19% (95% CI, 13%-24%); and at 12 months, 16% (95% CI, 15%-16%). In patients who underwent total knee arthroplasty, rates of postoperative opioid use were as follows: at 3 months, 26% (95% CI, 19%-33%); at 6 months, 20% (95% CI, 17%-24%); at 9 months, 23% (95% CI, 17%-28%); and at 12 months, 21% (95% CI, 12%-29%). Opioid naïve patients were less likely to have continued postoperative opioid use than those who were opioid tolerant preoperatively. Conclusion Over 1 in 5 patients continued opioid use for longer than 3 months after total hip or knee arthroplasty. Clinicians should be aware of this trajectory of opioid consumption after surgery.


2019 ◽  
Vol 34 (8) ◽  
pp. 1815-1822 ◽  
Author(s):  
Nathanael D. Heckmann ◽  
Cory K. Mayfield ◽  
Chris N. Culvern ◽  
Daniel A. Oakes ◽  
Jay R. Lieberman ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document